Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.40 |
| ▸ | HINT1 | P49773 | 1/20 | 0.40 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.39 |
| ▸ | IMPDH2 | P12268 | 2/20 | 0.39 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.39 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.38 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13715736 | 1.00 | HPGD (0.47) | HPGDPAX8ADORA2AADORA3ADORA1 | |
| SCHEMBL13744363 | 1.00 | HPGD (0.47) | HPGDPAX8ADORA2AADORA3ADORA1 | |
| SCHEMBL7708728 | 0.88 | HPGD (0.52) | HPGDPAX8ADORA2AADORA3ADORA1 | |
| SCHEMBL7708715 | 0.88 | HPGD (0.52) | HPGDPAX8ADORA2AADORA3ADORA1 | |
| SCHEMBL31040187 | 0.86 | HPGD (0.46) | HPGDPAX8ADORA3ADORA1HINT1 | |
| SCHEMBL7259250 | 0.85 | HPGD (0.64) | HPGDPAX8ADORA2AADORA3ADORA1 | |
| SCHEMBL7259261 | 0.85 | HPGD (0.64) | HPGDPAX8ADORA2AADORA3ADORA1 | |
| SCHEMBL19128427 | 0.85 | HPGD (0.64) | HPGDPAX8ADORA2AADORA3ADORA1 | |
| SCHEMBL22571072 | 0.85 | HPGD (0.64) | HPGDPAX8ADORA2AADORA3ADORA1 | |
| SCHEMBL19035723 | 0.85 | HPGD (0.64) | HPGDPAX8ADORA2AADORA3ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7569685-B2 | Artificial RNAóS modified at the 2ó-hydroxyl group | JAPAN SCIENCCE AND TECHNOLOGY AGENCY (JP) | 2009-08-04 | — | — | US | claimed |
| US-20080021206-A1 | Novel Artificial Rnaos Modified At The 2o-Hydroxyl Group | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-01-24 | — | — | US | claimed |
| EP-1726597-A1 | NOVEL ARTIFICIAL RNAóS MODIFIED AT THE 2ó-HYDROXYL GROUP | Japan Science and Technology Agency (JP) | 2006-11-29 | — | — | EP | claimed |
| US-7569685-B2 | Artificial RNAóS modified at the 2ó-hydroxyl group | JAPAN SCIENCCE AND TECHNOLOGY AGENCY (JP) | 2009-08-04 | — | — | US | disclosed |
| US-20080021206-A1 | Novel Artificial Rnaos Modified At The 2o-Hydroxyl Group | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-01-24 | — | — | US | disclosed |
| EP-1726597-A1 | NOVEL ARTIFICIAL RNAóS MODIFIED AT THE 2ó-HYDROXYL GROUP | Japan Science and Technology Agency (JP) | 2006-11-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021206-A1 | Novel Artificial Rnaos Modified At The 2o-Hydroxyl Group | FBL, NSUN2, METTL16 | HPGD 2770/4885PAX8 2575/4885ADORA2A 762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.